The Deep-Tech Gamble: Can Molagri's 'War Chest' Break Toronto's SaaS Habit?

Opinion: Toronto is a city that loves a scalable software play. We are excellent at SaaS, but we are often timid when it comes to the 'hard' side of hard tech. As BetaKit first reported, Molagri is exactly the kind of high-science, high-risk bet this ecosystem needs right now.

Founded by Zaky Hassan and Min Jin—two University of Toronto PhD candidates who specialized in common cold coronaviruses—Molagri isn't building another app. The startup is leveraging AI-driven advancements in protein design to create pesticides that can evolve as quickly as the pests they target. By building on a non-infectious insect virus, the company can engineer proteins to 'whitelist' and 'blacklist' targets, allowing them to tweak formulations to stay ahead of pest resistance. Hassan compares the model to a flu vaccine: the farmer shouldn't have to worry about the specific strain; the company handles the evolution in the back end.

But the real story here isn't just the science; it's the funding gap. According to BetaKit, Hassan and Jin initially sought Canadian investors to fund their vision but were unsuccessful. Hassan attributed this failure to the risk aversion of investors within Canada.

It is a familiar narrative. When the science is this deep, local capital often flinches. Consequently, the founders had to look south, securing $1 million USD (approximately $1.4 million CAD) in pre-seed funding from Y Combinator and the US-based deep-tech VC firm Julian Capital. This capital allowed them to secure lab space at the MaRS Discovery District and hire their first scientist.

Now, the stakes are higher. Hassan told BetaKit that the goal is to use their Y Combinator Demo Day appearance on Sept. 10 to kick off a seed raise. He describes the goal as returning to Toronto with a 'war chest' to hire more scientists and develop products for farmers. Currently, the company is focusing its initial efforts on tree fruits and tree nuts—specifically in California—due to an 'acute insecticide need.'

While the immediate revenue opportunity may be in the US, Hassan is adamant about the importance of the local scene. He told BetaKit that he is a proponent of building bio companies in Toronto to ensure a strong ecosystem, noting that the city is a 'crazy place for talent' filled with brilliant grad students and postdocs.

The question remains: is a YC-backed war chest enough to sustain a deep-tech powerhouse in a city that prefers the safety of software? If Molagri succeeds in scaling its evolutionary pesticides here, it won't just be a win for farmers; it will be a necessary wake-up call for Canadian VCs who let a high-potential bio-startup slip through their fingers.